NCT00587301已完成不适用
A Prospective, Open-label Study to Evaluate the Safety and Efficacy of Lap-Band® Adjustable Gastric Band (LAGB®) Operations in the Treatment of Morbidly Obese Adolescents (Ages 14-17)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 119
- 试验地点
- 1
- 主要终点
- Percentage of Excess Weight Loss (EWL)
研究概览
简要总结
This study is to demonstrate the safety and efficacy of the use of the LAP-BAND surgery in the morbidly obese adolescent population.
详细描述
STUDY OBJECTIVES: Is to demonstrate the safety and efficacy of the use of the LAP-BAND® System in the morbidly obese adolescent population in the United States, and therefore provide these individuals with a significantly less morbid and reversible surgical option for weight loss.
STUDY VARIABLES:The primary efficacy variable is weight loss evaluated in terms of % excess weight loss (EWL).
DESIGN:Prospective, open-label, and single center
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 14 Years 至 17 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Be at least 14 and less than 18 years of age at the time of enrollment into the study.
- •Have a BMI of at least 40
- •Have a history of obesity for at least 5 years, including failed attempts at diet and medical management of obesity.
- •Confirmation by a psychologist or psychiatrist experienced with adolescents that the subject is sufficiently mature emotionally to comply with the study protocol.
- •Express willingness to follow protocol requirements.
- •Assure investigators that subject, if female of childbearing potential, is using an appropriate form of contraception.
排除标准
- •Intention or need to have another surgical procedure for weight reduction within 12 months of Lap Band placement.
- •History of congenital or acquired anomalies of the G.I. tract, such as; congenital or acquired intestinal telangiectasia, Crohn's disease or ulcerative colitis; severe cardiopulmonary disease or severe coagulopathy; hepatic insufficiency or cirrhosis.
- •Presence of dysphagia or documented esophageal dysmotility.
- •Patients with autoimmune connective tissue disorders
- •Patients with acute abdominal infections
- •Pregnancy or intention of becoming pregnant in the next 12 months.
- •Presence of psychiatric problems or immaturity which would compromise cooperation with the study protocol.
- •History of previous bariatric surgery, intestinal obstruction or adhesive peritonitis.
- •Presence of localized or systemic infection at the time of surgery.
- •Chronic use of aspirin and/or non-steroidal anti-inflammatory medications and unwillingness to discontinue the use of these concomitant medications.
- •History of gastric or esophageal surgery.
- •Use of weigh loss medications simultaneously
结局指标
主要结局
Percentage of Excess Weight Loss (EWL)
时间窗: Year 5
次要结局
- Body Mass Index (BMI)(Year 5)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Effectiveness and Safety Study of LAP-BAND Treatment for Obese AdolescentsMorbid ObesityNCT00447590Apollo Endosurgery, Inc.153
已完成
不适用
Effectiveness and Safety Study of LAP-BAND Treatment in Subjects With BMI >/= 30 kg/m2 and < 40 kg/m2ObesityNCT00570505Apollo Endosurgery, Inc.151
已完成
不适用
Laparoscopic Adjustable Gastric Banding as a Treatment for Morbid Obesity in AdolescentsMorbid ObesityNCT00592202University of Illinois at Chicago37
撤回
2 期
LGCP (Laparoscopic Greater Curvature Plication)ObesityNCT01393886NYU Langone Health
撤回
不适用
Minimally Invasive Surgery Versus Traditional Open Surgery In The Treatment Of Single Level Lumbar StenosisIntervertebral Disc DegenerationLumbar Spinal StenosisNCT04408846Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan